Position in CLGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,741
+$1,501 QoQ
Shares Held
53,700
+67.0% QoQ
Ownership
0.284%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 15 holders
Holding Since
Jun 2021
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLGN Over Time
Shares Held
Position Value (USD)
Derivatives in CLGN
reported options exposure · as of Mar 31, 2024CallValue
$1,070
CallShares
200
PutValue
$2,675
PutShares
500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. CLGN ranks #420 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in CLGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,741 | 53,700 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $17,240 | 32,165 | Shares | Defined | 2026-05-15 | |
| 2024-03-31 | $1,070 | 200 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $70,582 | 13,193 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $2,675 | 500 | Put | Defined | 2024-05-15 | |
| 2023-12-31 | $10,863 | 1,700 | Put | Defined | 2024-02-14 | |
| 2023-12-31 | $43,030 | 6,734 | Shares | Defined | 2024-02-14 | |
| 2023-12-31 | $11,502 | 1,800 | Call | Defined | 2024-02-14 | |
| 2022-03-31 | $131,274 | 11,700 | Call | Defined | 2022-05-16 | |
| 2021-06-30 | $276,451 | 13,034 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||